Richard A. Larson
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 606
- Acute Myeloid Leukemia Research 387
- Chronic Myeloid Leukemia Treatments 279
- Hematopoietic Stem Cell Transplantation 83
- Genetics 300
- Chronic Lymphocytic Leukemia Research 234
- Myeloproliferative Neoplasms: Diagnosis and Treatment 62
- Co-authors
- Clara D. BloomfieldMichelle M. Le BeauAndreas HochhausTimothy A. SpringerFrederick R. AppelbaumCharles A. SchifferBayard L. PowellTimothy P. Hughes
- Journals
- Blood (265 papers)Journal of Clinical Oncology (112 papers)Leukemia (21 papers)Cancer (21 papers)British Journal of Haematology (20 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Richard A. Larson
981 papers receiving 55.3k citations
Hit Papers
Peers
Comparison fields: 5 of 221
- Hematology 33.9k
- Genetics 16.7k
- Public Health, Environmental and Occupational Health 11.4k
- Rheumatology 5.8k
- Oncology 8.8k
Countries citing papers authored by Richard A. Larson
This map shows the geographic impact of Richard A. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Larson more than expected).
Fields of papers citing papers by Richard A. Larson
This network shows the impact of papers produced by Richard A. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Larson. The network helps show where Richard A. Larson may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard A. Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 19 | |
| 7 | 2018 | 47 | |
| 8 | 2018 | 113 | |
| 9 | 2011 | 102 | |
| 10 | GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS | 2011 | 2 |
| 11 | 2010 | 69 | |
| 12 | 2009 | 241 | |
| 13 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2350 |
| 14 | 2008 | 224 | |
| 15 | Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study Hit paper breakdown → | 2008 | 491 |
| 16 | 2007 | 256 | |
| 17 | 2007 | 300 | |
| 18 | 2000 | 7 | |
| 19 | Activating RAS mutations in therapy-related myeloid disorders associated with deletions of chromosomes 5 and 7. | 1996 | 4 |
| 20 | 1989 | 458 |
About Richard A. Larson
Richard A. Larson is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Rheumatology and Oncology, having authored 994 papers that have together received 57.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (387 papers), Chronic Myeloid Leukemia Treatments (279 papers), Acute Lymphoblastic Leukemia research (254 papers), Chronic Lymphocytic Leukemia Research (234 papers), Hematopoietic Stem Cell Transplantation (83 papers), Eosinophilic Disorders and Syndromes (67 papers), Lymphoma Diagnosis and Treatment (65 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (62 papers). The work is most often cited by research in Hematology (33.9k citations), Genetics (16.7k citations), Public Health, Environmental and Occupational Health (11.4k citations), Rheumatology (5.8k citations) and Oncology (8.8k citations). Richard A. Larson has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Clara D. Bloomfield, Michelle M. Le Beau, Andreas Hochhaus, Timothy A. Springer, Frederick R. Appelbaum, Charles A. Schiffer, Bayard L. Powell, Timothy P. Hughes, Janet D. Rowley and James W. Vardiman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.